Cedeño, Rosselle Kim .

HRN: 27-23-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
METRONIDAZOLE 500MG (TAB)
06/21/2025
06/28/2025
ORAL
500mg
TID
S/P NSD With Repair; Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: